US2011207707A1PendingUtilityA1
Compounds That Act To Modulate Insect Growth And Methods And Systems For Identifying Such Compounds
Individually held — no corporate assignee on recordPriority: Aug 29, 2003Filed: Jul 26, 2010Published: Aug 25, 2011
Est. expiryAug 29, 2023(expired)· nominal 20-yr term from priority
G01N 2333/43552A01N 61/00C12Q 1/6897G01N 33/743
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed are methods and systems for screening for compounds that act to modulate insect growth. Bioassays including cell culture and/or transgenic insects engineered with various components of the ecdysoid receptor (EcR) and/or the farsenoid-X receptor (RXR) systems to identify compounds that act as insecticides and/or hormone receptor activators are described. Also described are compounds, and compositions, identified as being putative insecticides based upon their ability to activate EcR and/or FXR mediated transcription.
Claims
exact text as granted — not AI-modified1 . A method for testing the ability of a compound to act as a modulator of insect growth comprising determining whether the compound increases farnesoid X-activated receptor (FXR)-mediated transcription and/or ecdysone receptor (EcR)-mediated transcription.
2 . The method of claim 1 , wherein the increase of EcR-mediated transcription comprises potentiation of hormone-activated EcR-mediated transcription.
3 . The method of claim 2 , wherein the hormone comprises an ecdysteroid.
4 . The method of claim 3 , wherein the hormone comprises muristerone A (murA) or 20-hydroxyecdysone (20E).
5 . The method of claim 1 , comprising the steps of:
(a) transfecting isolated cells with DNA comprising sequences that encode a functional isoform of the ecdysone receptor (EcR) or the farnesoid receptor (FXR); (b) cotransfecting the cell with: (i) DNA comprising sequences that encode a functional heterologous binding partner for (a), wherein said heterologous binding partner complexes with either EcR or FXR, and wherein said complex binds to a hormone responsive element (HRE) on DNA to activate gene transcription; and (ii) DNA comprising a reporter construct comprising a hormone response element (HRE) linked to a gene; (c) adding the compound to be tested; and (d) measuring an increase in the synthesis of the reporter gene protein.
6 . The method of claim 5 , wherein the increase in reporter gene protein is used to quantify the ability of the test compound to increase EcR-mediated transcription or FXR-mediated transcription.
7 . The method of claim 6 , wherein the ability of the test compound to activate EcR-mediated transcription or FXR-mediated transcription is correlated to the potential insecticidal activity of the test compound.
8 . The method of claim 5 , wherein the heterologous binding partner comprises Ultraspiracle (USP).
9 . The method of claim 5 , wherein the heterologous binding partner comprises a retinoid X receptor (RXR).
10 . The method of claim 5 , further comprising adding a modulator of EcR activity to the cell.
11 . A method for in situ testing for the presence of compound having the ability to act as a modulator of insect growth comprising:
(a) transfecting a cell in an organism with DNA that encodes a functional isoform of the farnesoid X-activated receptor (FXR) and/or the ecdysone receptor (EcR); (b) cotransfecting the cell with: (i) DNA that encodes a polypeptide comprising a functional retinoid X receptor (RXR) or Ultraspiracle (USP) isoform; and (ii) DNA comprising a hormone response element (HRE) linked to a reporter gene; (c) optionally adding an ecdysteroid; (d) exposing the organism to a compound to be tested; and (e) measuring an increase in the protein encoded by the reporter gene.
12 . The method of claim 11 , wherein the organism comprises a natural or modified eukaryotic cell.
13 . The method of claim 11 , wherein the reporter construct comprises a promoter comprising multiple hormone response elements (HREs) linked to a gene encoding a detectable gene product.
14 . The method of claim 11 , wherein the reporter gene comprises luciferase (LUC).
15 . The method of claim 11 , wherein the hormone response element comprises a EcR response element.
16 . The method of claim 11 , wherein the hormone response element comprises a FXR response element.
17 . A composition for use as an insecticide comprising a compound that increases FXR-mediated transcription or EcR-mediated transcription mixed with a suitable carrier for application to plants.
18 . The composition of claim 17 , wherein the increase in EcR-mediated transcription comprises potentiation of hormone-activated EcR transcription.
19 . The composition of claim 17 , wherein the hormone comprises an ecdysteroid.Join the waitlist — get patent alerts
Track US2011207707A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.